NORVELZO

Mumbai, India Founded: 2014 • Age: 12 yrs
Serves as a distributor of generic pharmaceutical drugs to healthcare providers.
Annual revenue $581,385 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About NORVELZO

NORVELZO is a company based in Mumbai (India) founded in 2014. It operates as a B2B. NORVELZO operates in a competitive market with competitors including Pfizer, AmerisourceBergen, Entero Healthcare, Target Healthcare and CHEPLAPHARM, among others.

  • Headquarter Mumbai, India
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Taj Pharmaceuticals Limited
  • Date of Incorporation 05 Nov, 2004
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $581.39 K (USD)
    42.79
    as on Mar 31, 2023
  • Net Profit
    $11.63 K (USD)
    19.54
    as on Mar 31, 2023
  • EBITDA
    -$162.2 K (USD)
    -608.3
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of NORVELZO

Premium access

Detailed funding history for NORVELZO

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by NORVELZO

Investments
Premium access

Investment portfolio details for NORVELZO

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - NORVELZO

Premium access

Detailed financials for NORVELZO

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Norvelzo Comparisons

NORVELZO Primary company
Description
Serves as a distributor of generic pharmaceutical drugs to h...
Location
Mumbai, India
Founded Year
2014
Annual Revenue
$581.39 K (USD)
Net Profit
$11.63 K (USD)
EBITDA
-$162.2 K (USD)
Employees
Not available
Premium access

Peer comparison for NORVELZO

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of NORVELZO

NORVELZO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pfizer, AmerisourceBergen, Entero Healthcare, Target Healthcare and CHEPLAPHARM, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical products for treating multiple diseases are provided.
Locked Locked Locked
Pharmaceutical distribution and supply chain services are provided globally.
Locked Locked Locked
India's leading healthcare products distribution platform
Locked Locked Locked
Distributor of pharmaceutical products
Locked Locked Locked
Branded pharmaceutical products are developed, marketed, and distributed globally.
Locked Locked Locked
Wholesaler & distributor of healthcare, medical, and pharmaceutical products
Premium access

Detailed competitors of NORVELZO

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Norvelzo

Premium access

Complete news archive for NORVELZO

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about NORVELZO

NORVELZO was founded in 2014.

NORVELZO is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Annual revenue of NORVELZO is $581.39K as on Mar 31, 2023.

NORVELZO serves as a distributor of generic pharmaceutical drugs to healthcare providers through providing healthcare solutions, producing pharmaceutical products, distribution, and generic drugs. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

NORVELZO's top competitors include Pfizer, Entero Healthcare and AmerisourceBergen.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available